BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

533212

GKB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GKB OPHTHALMICS LTD. Share Price Update

As of the latest trading session, GKB OPHTHALMICS LTD. share price is currently at ₹ 76.3, which is down by ₹ -2.68 from its previous closing. Today, the stock has fluctuated between ₹ 76.23 and ₹ 78.99. Over the past year, GKB OPHTHALMICS LTD. has achieved a return of -31.97 %. In the last month alone, the return has been -2.72 %. Read More...

Investment Returns

Over 1 Month -2.72% Over 3 Months 1.51% Over 6 Months 8.25% Over 1 Year -31.97%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GKB OPHTHALMICS LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    38.50

  • P/E Ratio (TTM)

    -5.82

  • Beta

    0.82

  • Book Value / share

    35.06

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -2.14

info icon alternate text

GKB OPHTHALMICS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 8.77
Operating Expense 10.96
Net Profit -2.14
Net Profit Margin (%) -24.40
Earnings Per Share (EPS) -4.25
EBITDA -0.77
Effective Tax Rate (%) -0.93
Particulars MAR 2025 (Values in Cr)
Revenue 8.43
Operating Expense 10.87
Net Profit -2.48
Net Profit Margin (%) -29.41
Earnings Per Share (EPS) -4.92
EBITDA -1.17
Effective Tax Rate (%) -1.63
Particulars DEC 2024 (Values in Cr)
Revenue 7.45
Operating Expense 9.42
Net Profit -0.17
Net Profit Margin (%) -2.28
Earnings Per Share (EPS) -0.33
EBITDA 0.99
Effective Tax Rate (%) -6.25
Particulars SEP 2024 (Values in Cr)
Revenue 8.26
Operating Expense 10.36
Net Profit -2.05
Net Profit Margin (%) -24.81
Earnings Per Share (EPS) -4.07
EBITDA -0.98
Effective Tax Rate (%) -0.49
Particulars JUN 2024 (Values in Cr)
Revenue 8.62
Operating Expense 10.10
Net Profit -1.41
Net Profit Margin (%) -16.35
Earnings Per Share (EPS) -2.80
EBITDA -0.33
Effective Tax Rate (%) -0.71
Particulars MAR 2025 (Values in Cr)
Revenue 32.75
Operating Expense 40.76
Net Profit -6.11
Net Profit Margin (%) -18.65
Earnings Per Share (EPS) -12.12
EBITDA -1.51
Effective Tax Rate (%) -1.15
Particulars MAR 2024 (Values in Cr)
Revenue 31.18
Operating Expense 36.63
Net Profit -3.42
Net Profit Margin (%) -10.96
Earnings Per Share (EPS) -6.78
EBITDA 0.80
Effective Tax Rate (%) -1.18
Particulars MAR 2023 (Values in Cr)
Revenue 27.73
Operating Expense 32.86
Net Profit -2.88
Net Profit Margin (%) -10.38
Earnings Per Share (EPS) -5.72
EBITDA 1.00
Effective Tax Rate (%) 5.26
Particulars MAR 2022 (Values in Cr)
Revenue 27.05
Operating Expense 31.32
Net Profit -2.31
Net Profit Margin (%) -8.53
Earnings Per Share (EPS) -4.58
EBITDA 1.52
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 21.34
Operating Expense 26.25
Net Profit -2.11
Net Profit Margin (%) -9.88
Earnings Per Share (EPS) -4.18
EBITDA 2.04
Effective Tax Rate (%) 7.86
Particulars MAR 2025 (Values in Cr)
Book Value / Share 103.24
ROE % -12.66
ROCE % -6.05
Total Debt to Total Equity 0.23
EBITDA Margin -1.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.58
ROE % -4.87
ROCE % -1.15
Total Debt to Total Equity 0.19
EBITDA Margin 2.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 124.38
ROE % 0.22
ROCE % 2.28
Total Debt to Total Equity 0.18
EBITDA Margin 6.07
Particulars MAR 2022 (Values in Cr)
Book Value / Share 125.17
ROE % 3.09
ROCE % 4.47
Total Debt to Total Equity 0.19
EBITDA Margin 8.60
Particulars MAR 2021 (Values in Cr)
Book Value / Share 124.30
ROE % 0.43
ROCE % 2.79
Total Debt to Total Equity 0.22
EBITDA Margin 9.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 35.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.70
EBITDA Margin -4.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 47.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.43
EBITDA Margin 2.57
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.40
EBITDA Margin 3.61
Particulars MAR 2022 (Values in Cr)
Book Value / Share 60.32
ROE % -7.31
ROCE % -2.12
Total Debt to Total Equity 0.38
EBITDA Margin 5.62
Particulars MAR 2021 (Values in Cr)
Book Value / Share 65.01
ROE % -3.23
ROCE % 0.13
Total Debt to Total Equity 0.32
EBITDA Margin 14.29
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 13.82
Total Assets 125.21
Total Liabilities 125.21
Total Equity 56.43
Share Outstanding 5040580
Price to Book Ratio 1.72
Return on Assets (%) -5.62
Return on Capital (%) -9.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 17.83
Total Assets 114.50
Total Liabilities 114.50
Total Equity 64.20
Share Outstanding 5040580
Price to Book Ratio 1.83
Return on Assets (%) -2.45
Return on Capital (%) -3.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.45
Total Assets 112.08
Total Liabilities 112.08
Total Equity 67.29
Share Outstanding 5040600
Price to Book Ratio 1.99
Return on Assets (%) -0.14
Return on Capital (%) -0.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 16.39
Total Assets 110.15
Total Liabilities 110.15
Total Equity 67.41
Share Outstanding 5040600
Price to Book Ratio 1.53
Return on Assets (%) 1.15
Return on Capital (%) 1.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 17.28
Total Assets 106.81
Total Liabilities 106.81
Total Equity 66.30
Share Outstanding 5040600
Price to Book Ratio 1.26
Return on Assets (%) -0.84
Return on Capital (%) -1.16
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.88
Total Assets 49.48
Total Liabilities 49.48
Total Equity 17.67
Share Outstanding 5040580
Price to Book Ratio 1.72
Return on Assets (%) -12.34
Return on Capital (%) -17.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 48.39
Total Liabilities 48.39
Total Equity 23.98
Share Outstanding 5040580
Price to Book Ratio 1.83
Return on Assets (%) -7.05
Return on Capital (%) -9.74
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 49.14
Total Liabilities 49.14
Total Equity 27.51
Share Outstanding 5040600
Price to Book Ratio 1.99
Return on Assets (%) -5.86
Return on Capital (%) -7.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.43
Total Assets 53.89
Total Liabilities 53.89
Total Equity 30.40
Share Outstanding 5040600
Price to Book Ratio 1.53
Return on Assets (%) -4.28
Return on Capital (%) -5.48
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.09
Total Assets 56.86
Total Liabilities 56.86
Total Equity 32.77
Share Outstanding 5040600
Price to Book Ratio 1.26
Return on Assets (%) -3.70
Return on Capital (%) -4.71
Particulars MAR 2025 (Values in Cr)
Net Income -6.72
Cash from Operations -3.29
Cash from Investing 2.54
Cash from Financing 0.66
Net change in Cash -0.21
Free Cash Flow -1.14
Particulars MAR 2024 (Values in Cr)
Net Income -2.77
Cash from Operations 4.40
Cash from Investing -1.71
Cash from Financing -1.63
Net change in Cash 0.86
Free Cash Flow 6.48
Particulars MAR 2023 (Values in Cr)
Net Income 0.13
Cash from Operations -2.60
Cash from Investing 1.42
Cash from Financing -2.18
Net change in Cash -3.52
Free Cash Flow -1.39
Particulars MAR 2022 (Values in Cr)
Net Income 1.94
Cash from Operations 5.14
Cash from Investing -3.52
Cash from Financing -1.66
Net change in Cash -0.12
Free Cash Flow 9.90
Particulars MAR 2021 (Values in Cr)
Net Income -0.92
Cash from Operations 6.89
Cash from Investing -16.77
Cash from Financing 2.76
Net change in Cash -7.15
Free Cash Flow 13.22
Particulars MAR 2025 (Values in Cr)
Net Income -6.03
Cash from Operations -5.00
Cash from Investing -0.15
Cash from Financing 5.12
Net change in Cash -0.07
Free Cash Flow -3.58
Particulars MAR 2024 (Values in Cr)
Net Income -3.37
Cash from Operations 1.37
Cash from Investing 0.37
Cash from Financing -1.73
Net change in Cash 0.00
Free Cash Flow 2.62
Particulars MAR 2023 (Values in Cr)
Net Income -3.03
Cash from Operations -1.10
Cash from Investing 2.39
Cash from Financing -2.02
Net change in Cash -0.77
Free Cash Flow -0.29
Particulars MAR 2022 (Values in Cr)
Net Income -2.30
Cash from Operations 2.33
Cash from Investing -0.83
Cash from Financing -1.49
Net change in Cash 0.00
Free Cash Flow 6.14
Particulars MAR 2021 (Values in Cr)
Net Income -2.28
Cash from Operations 2.11
Cash from Investing -11.52
Cash from Financing 0.61
Net change in Cash -8.80
Free Cash Flow 5.75
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5845.10 64.18 32.32 140789.93 4506.50 / 6473.10
NESTLE INDIA LIMITED 1174.20 76.20 56.46 226422.67 1057.50 / 1388.50
FOODS & INNS LIMITED 89.60 15.66 1.22 657.80 75.20 / 147.80
HINDUSTAN UNILEVER LTD. 2648.20 58.51 12.59 622218.76 2136.00 / 3034.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5845.10 66.19 36.22 140789.93 4506.50 / 6473.10
COLGATE PALMOLIVE LTD. 2360.40 46.07 38.57 64199.49 2151.00 / 3893.00
NESTLE INDIA LIMITED 1174.20 75.27 54.99 226422.67 1057.50 / 1388.50
FOODS & INNS LIMITED 89.60 14.74 1.21 657.80 75.20 / 147.80

GKB OPHTHALMICS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
76.30 -3.39 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 79.00
  • 26 Days 78.10
  • 10 Days 79.10
  • 50 Days 77.10
  • 12 Days 79.00
  • 100 Days 77.50
  • 20 Days 78.50
  • 200 Days 81.90
77.97 PIVOT

First Support

76.13

First Resistance

80.81

Second Support

73.29

Second Resistance

82.65

Third Support

71.45

Third Resistance

85.49

RSI

51.77

ADX

22.81

MACD

0.88

Williams % R

-71.86

Commodity Channel Index (CCI)

-35.16

Date

2025-09-01

Week

2256.00

Same Day

190.00

Month

3643.00

1 Year

0.83

3 Year

0.76

Over 1 Month

-2.72%

down

Over 1 Year

-31.97%

down

Over 3 Months

1.51%

down

Over 3 Years

-6.78%

down

Over 6 Months

8.25%

down

Over 5 Years

7.34%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

GKB OPHTHALMICS LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

GKB OPHTHALMICS LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Sep 2010 1.2 Final 23 Sep 2010 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

GKB OPHTHALMICS LTD. Share Price

Incorporated in Dec.'81 as a public limited company, GKB Opthalmics was granted a licence as a 100% EOU in 1982. The company set up a plant at Tivim, Goa, with financial assistance from the Economic Development Corporation of Goa, Daman and Diu Ltd and The Maharashtra State Financial Corporation. It was promoted by K G Gupta, K M Gupta, B K Gupta and Ravi Gupta. Presently, the Company is engaged in manufacture and sale of unfinished ophthalmic lenses and manufactures 14,000 pieces per day of plastic lenses.

The company is engaged in the manufacture and export of high-quality, single-vision mineral opthalmic lenses. Commercial production commenced in May '83. It has an installed capacity of 30 lac lenses pa. The company completed the expansion programme by expanding the capacity of single vision lenses to 33 lac pcs pa. It also installed facilities for coating 1.72 lac pcs of lenses pa. The above project was completed at a new loacation -- Pilerne Industrial Estate, Bardez-Goa. The company has shifted the single vision plant to the new premises in phases. In 1996-97, it increased the installed capacity of ophthamal lenses by 9,00,000 nos to 30,00,000 nos.

The establishment of Company's fully owned subsidiary in Germany in 1998 was a turning point in creating a strong market base in Europe. The company floated a wholly owned subsidiary (WOS) at Bermen, Germany which acts as a stock point and have proper liasion with the buyers in and around Europe.

During the year 2007-08, the Company started the production of CR 39 lenses in its Unit 2. On October 05, 2018, GSV Ophthalmics Private Limited was incorporated as Wholly Owned Subsidiary of the Company. GSV Ophthalmics Private Limited is another Subsidiary of the Company, which was incorporated to produce Hi-Index Ophthalmic Lenses, however, the Project had become financially unviable and therefore the Company is in the discussion of coming up with an alternate expansion plan.

Parent organization Indian Private
NSE symbol GKB
Founded 1981
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of GKB Ophthalmics Ltd?

Answer Field

GKB Ophthalmics Ltd share price is for NSE ₹ 84.05 & for BSE ₹ 76.30 as on Sep 02 2025 03:28 PM.

What is the Market Cap of GKB Ophthalmics Ltd Share?

Answer Field

The market cap of GKB Ophthalmics Ltd for NSE ₹ 0.00 & for BSE ₹ 38.50 as on Sep 02 2025 03:28 PM.

What is the 52 Week High and Low of GKB Ophthalmics Ltd?

Answer Field

The 52 Week High and Low of GKB Ophthalmics Ltd for NSE is ₹ 90.90 and ₹ 0.00 and for BSE is ₹ 123.90 and ₹ 59.00.

What is 1 year return for GKB Ophthalmics Ltd?

Answer Field

The 1 year returns on the stock has been -31.97%.

What is the P/E Ratio of GKB Ophthalmics Ltd Share?

Answer Field

As on Sep 02 2025 03:28 PM the price-to-earnings (PE) ratio for GKB Ophthalmics Ltd share is -5.82.

What is the PB ratio of GKB Ophthalmics Ltd Share?

Answer Field

As on Sep 02 2025 03:28 PM, the price-to-book (PB) ratio for GKB Ophthalmics Ltd share is 35.06.

How to Buy GKB Ophthalmics Ltd Share?

Answer Field

You can trade in GKB Ophthalmics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy GKB Ophthalmics Ltd Share on Bajaj Broking App?

Answer Field

To buy GKB Ophthalmics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “GKB Ophthalmics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91